Ken Griffin Humacyte, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Humacyte, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 15,600 shares of HUMA stock, worth $74,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,600
Previous 1,500
940.0%
Holding current value
$74,880
Previous $4,000
1100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HUMA
# of Institutions
100Shares Held
23.1MCall Options Held
67.8KPut Options Held
198K-
Black Rock Inc. New York, NY4.79MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$19.3 Million0.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.16MShares$10.3 Million2.7% of portfolio
-
Sio Capital Management, LLC New York, NY2MShares$9.6 Million2.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.35MShares$6.48 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $494M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...